SCHEMBL8547835

SCHEMBL8547835

CC(C)C[C@@H](CN1CCC[C@H]1C(=O)NCCCCc1ccccc1)NS(=O)(=O)c1c(C(C)C)cc(C(C)C)cc1C(C)C

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 15/20 0.47
PLAU P00749 3/20 0.44
PLAT P00750 1/20 0.44
F10 P00742 3/20 0.42
F2 P00734 3/20 0.41
PLG P00747 2/20 0.41
ST14 Q9Y5Y6 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8547442 0.85 FKBP1A (0.54) FKBP1A
SCHEMBL8547438 0.85 FKBP1A (0.54) FKBP1A
SCHEMBL8544850 0.85 FKBP1A (0.54) FKBP1A
SCHEMBL8543354 0.84 FKBP1A (0.60) FKBP1A
SCHEMBL8543352 0.84 FKBP1A (0.60) FKBP1A
SCHEMBL8544141 0.83 PLAU (0.42) PLAUPLATF10F2PLG
SCHEMBL8546841 0.83 FKBP1A (0.48) FKBP1A
SCHEMBL8546843 0.83 FKBP1A (0.48) FKBP1A
SCHEMBL8543982 0.82 FKBP1A (0.51) FKBP1A
SCHEMBL8541292 0.82 FKBP1A (0.51) FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0610744-B1 Sulfonamide aminomethylene derivatives as immunosuppressants BAYER AG (US) 1998-11-04 EP claimed
US-5633277-A ANTIINFLAMMATORY MILES INC. (US) 1997-05-27 US claimed
EP-0610744-A1 Sulfonamide aminomethylene derivatives as immunosuppressants Bayer Corporation (US) 1994-08-17 EP claimed
EP-0610744-B1 Sulfonamide aminomethylene derivatives as immunosuppressants BAYER AG (US) 1998-11-04 EP disclosed
US-5633277-A ANTIINFLAMMATORY MILES INC. (US) 1997-05-27 US disclosed
EP-0610744-A1 Sulfonamide aminomethylene derivatives as immunosuppressants Bayer Corporation (US) 1994-08-17 EP disclosed